Real-world study of oral teriflunomide on fatigue in MS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how taking teriflunomide (an oral medication) affects tiredness and daily activities in people with relapsing multiple sclerosis. It will follow you for a year, checking your energy levels and physical function through simple tests and questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have relapsing multiple sclerosis (either RRMS or active SPMS)
- You are 18 years or older
- You have recently started or are about to start teriflunomide (a disease-modifying therapy)
- You can walk on your own, possibly with a cane or walker (EDSS score of 7 or less)
- You are not pregnant or breastfeeding
- You can complete study visits over 12 months and do simple tests like the 9-Hole Peg Test and Symbol Digit Modalities Test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether solriamfetol, a medication that promotes wakefulness, can reduce fatigue in people with multiple sclerosis. If you struggle with tiredness and sleepiness, this trial may help you understand how this drug works for MS-related fatigue.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
This study looks at whether the amount of MS treatment-related “burden” in the mouth and body affects how well people stick to their disease-modifying therapy. It may help doctors understand which patients are more likely to have trouble following treatment after switching or starting certain MS medicines.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This study will test different parts of cognitive behavioral therapy to see which ones help with fatigue in people with multiple sclerosis. You will participate in sessions that may involve changing thoughts about fatigue, scheduling activities, or addressing related emotions like depression or anxiety.
This trial tests if a smartphone app and activity tracker can help reduce fatigue in people with Multiple Sclerosis. You will use the app and wear a small device to track your activity, while receiving support to manage your energy levels. The goal is to see if this helps more than standard care alone.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.